Gamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation

This is an early safety study for a new lab-made antibody drug called B10-FC, designed to treat COVID-19 early in the illness. It will first test single doses in a small group of healthy adults, then in adults who have recently tested positive for COVID-19 and have mild to modera…

This is a very early study to check the safety of a new drug called Fluorothiazinone and see how the body processes it. It will involve 70 healthy adult volunteers. Researchers will first give single doses to small groups, watching for side effects, before testing a repeated dose…